Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study
Public ClinicalTrials.gov record NCT00439725. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Once-daily Oral Direct Factor Xa Inhibitor Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic Venous Thromboembolism in Patients With Symptomatic Deep-vein Thrombosis or Pulmonary Embolism. The Einstein-Extension Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, randomized, double-blind, placebo-controlled, event-driven, superiority study for efficacy. Patients with confirmed symptomatic DVT (deep vein thrombosis) or PE (pulmonary embolism) who completed 6 or 12 months of treatment with rivaroxaban or VKA (vitamin K antagonist) are eligible for this trial (Einstein-Extension study).
Study identification
- NCT ID
- NCT00439725
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,197 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2007 (Type not available)
- Primary completion
- Aug 2009 (Actual)
- Completion
- Sep 2009 (Actual)
- Last update posted
- Nov 4, 2014
2007 – 2009
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Los Angeles | California | 90095 | — |
| Not listed | Redlands | California | 92373 | — |
| Not listed | Bay Pines | Florida | 33744 | — |
| Not listed | Melbourne | Florida | 32901 | — |
| Not listed | Miami | Florida | 33136-1096 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Decatur | Georgia | 30033 | — |
| Not listed | Idaho Falls | Idaho | 83404 | — |
| Not listed | Covington | Louisiana | 70433 | — |
| Not listed | Baltimore | Maryland | 21215-5271 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Albuquerque | New Mexico | 87108 | — |
| Not listed | Chapel Hill | North Carolina | 27599-7035 | — |
| Not listed | Greensboro | North Carolina | 27401 | — |
| Not listed | Greensboro | North Carolina | 27403 | — |
| Not listed | Oklahoma City | Oklahoma | 73104 | — |
| Not listed | Pittsburgh | Pennsylvania | 15224 | — |
| Not listed | Corsicana | Texas | 75110 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Murray | Utah | 84107 | — |
| Not listed | Salt Lake City | Utah | 84132 | — |
| Not listed | Burlington | Vermont | 05401 | — |
| Not listed | Fredericksburg | Virginia | 22401 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 297 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00439725, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 4, 2014 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00439725 live on ClinicalTrials.gov.